Demant
Thomas C. Krohn is a highly experienced professional with over a decade of expertise in regulatory compliance and medical writing, currently serving as a Principal Compliance Specialist at Demant since July 2015. With a strong focus on regulatory intelligence, cyber security compliance, and Artificial Intelligence (AI), Thomas interprets and implements various regulations, manages 510(k) applications, and provides training in ISO13485 and MDR. Thomas also honed skills as a Senior Regulatory Affairs Officer at Oticon A/S and as a Senior Regulatory Professional at Novo Nordisk A/S. Additionally, Thomas is a crime fiction writer and the founder of KrohnBioConsult, specializing in Laboratory Animal Science and medical devices. Thomas holds a Cand.scient degree in Physiology and Biochemistry from the University of Southern Denmark.
Demant
14 followers
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect and communicate with the world around them. For more than a century, the Demant Group has played a vital part in developing innovative technologies and know-how to help improve people’s hearing and health. In every aspect, from hearing devices, hearing implants and diagnostic equipment to hearing care all over the world, Demant is active and engaged. The Demant Group operates in a global market with companies in more than 30 countries, employs more than 14,500 staff and generates annual revenue of DKK 14 billion. Our products are sold in more than 130 countries where we create life-changing differences through hearing health.